Clinical Trials Logo
  1. Home
  2. Polyneuropathy
  3. NCT00614562

Neurally Adjusted Ventilatory Assist (NAVA) in Patients With Critical Illness Associated Polyneuropathy / or Polymyopathy (CIP/M)

Polyneuropathy Clinical Trial

Official title:
Neurally Adjusted Ventilatory Assist (NAVA) in Patients With Critical Illness Associated Polyneuropathy / or Polymyopathy (CIP/M)

Clinical Trial Summary

Neurally adjusted ventilatory assist (NAVA) is a new concept of mechanical ventilation. NAVA delivers assist to spontaneous breathing based on the detection of the electrical activity of the diaphragm. We study the effect of NAVA in patients with critical illness associated polyneuropathy / polymyopathy (CIP/M)

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00614562
Study type Interventional
Source University Hospital Inselspital, Berne
Contact
Status Completed
Phase Phase 1
Start date January 2008
Completion date December 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT05560555 - Retrospective Study Collecting Neurological Follow-up of Hereditary Transthyretin Amyloidosis (ATTRv) Patients Included in B3461028 and B3461045.
Recruiting NCT02033057 - Muscular Electrostimulation of the Sedated and Mechanically Ventilated Critically Ill Patient. Analysis of the Effect on Acquired Muscular Weakness and Its Clinical Consequences. Phase 4
Withdrawn NCT02566941 - Neuromuscular Electrical Stimulation in the Critically Ill N/A
Completed NCT02442986 - Neurological Outcome in Surgical and Non-surgical Septic Patients N/A
Completed NCT02706314 - Impact of Human Blood Serum From Critically Ill Patients on Human Colon Neuronal Networks.
Completed NCT01076478 - Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines Phase 4
Completed NCT03373370 - Early Diagnosis of TTR Amyloidosis by Use of Molecular Biology
Completed NCT02846844 - Patients With Chemotherapy-induced Polyneuropathy Are Treated With an Integrated Program Including Massage, Mobilization in Posture and Transport Layers, Physical Exercises or With Whole-body Vibration Platform Training N/A
Recruiting NCT05950867 - Prevalence of Wild-type TTR Cardiac Amyloidosis in Patients With Polyneuropathy of Unknown Cause. N/A
Terminated NCT00832572 - Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy Phase 4
Completed NCT01302275 - Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain Phase 4
Terminated NCT01088256 - Efficacy of Etoricoxib on Peripheral Hyperalgesia Phase 2
Not yet recruiting NCT01047488 - Imipramine and Pregabalin Combination in Painful Polyneuropathy Phase 4
Recruiting NCT06414746 - Hereditary Transthyretin Amyloidosis Polyneuropathy in Patients With Carpal Tunnel Syndrome in Russia
Completed NCT04201418 - A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation
Completed NCT01450163 - Evaluate The Efficacy and Safety Of Pregabalin In Prevention, Reduction of Oxaliplatin-Induced Painful Neuropathy Phase 3
Recruiting NCT05040373 - Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
Not yet recruiting NCT02666456 - The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain N/A
Withdrawn NCT00723918 - Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy Phase 2
Completed NCT00259974 - RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy Phase 3